Gut Microbiota Market Size Forecast: Revenue and CAGR by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Gut Microbiota Industry In 2025?

The gut microbiota market has experienced substantial expansion in recent years. It is anticipated to increase from $0.55 billion in 2024 to $0.65 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.9%. This historical growth can be ascribed to factors such as the discovery of probiotics and prebiotics, the rising prevalence of gastrointestinal disorders, growing consumer interest in functional foods, the expanded use of antibiotics, and increased awareness regarding the gut-brain axis.

The gut microbiota market is forecast to experience substantial expansion in the upcoming years. It is predicted to reach a valuation of $1.25 billion by 2029, achieving a compound annual growth rate (CAGR) of 17.9%. This projected increase during the forecast period stems from the broadening scope of personalized nutrition, a rising consumer need for microbiome-based therapeutics, the expansion of functional and fermented food markets, and supportive regulatory frameworks for probiotics and prebiotics. Key developments anticipated in this period include artificial intelligence (AI)-driven microbiome analysis, advancements in next-generation sequencing, CRISPR-based gut microbiota editing, the invention of smart probiotic delivery systems, and wearable devices designed for gut health monitoring.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

What Are The Main Drivers Boosting The Gut Microbiota Industry’s Expansion?

The increasing requirement for personalized medical treatments is projected to fuel the expansion of the gut microbiota market moving forward. Personalized medicine involves customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to achieve optimal outcomes and improve care. The demand for personalized medicine is escalating due to advancements in genomics and biotechnology, which allow for more precise identification of genetic profiles, leading to tailored treatments that enhance effectiveness and reduce adverse effects. Personalized medicine benefits the gut microbiota by enabling customized treatments based on an individual’s distinct microbiome composition, thereby optimizing gut health and improving results for digestive and metabolic disorders. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, which was a notable increase compared to the 12 approved in 2022. Therefore, the growing need for personalized medicine is driving the growth of the gut microbiota market.

What Are The Key Segments In The Gut Microbiota Market?

The gut microbiotamarket covered in this report is segmented –

1) By Product: Prebiotics; Probiotics; Drugs; Supplements; Other Products

2) By Application: Digestive Health; Immune Health; Weight Management; Mental Health; Cardiovascular Health

3) By Distribution Channel: Pharmacies And Drugstores; Online Retail; Health Food Stores; Supermarkets And Hypermarkets; Specialty Stores

4) By End-Users: Adults; Children; Elderly

Subsegments:

1) By Prebiotics: Fructooligosaccharides (Fos); Galactooligosaccharides (Gos); Inulin; Resistant Starch; Beta-Glucans; Arabinogalactans; Pectins

2) By Probiotics: Lactobacillus; Bifidobacterium; Saccharomyces; Streptococcus; Bacillus; Escherichia

3) By Drugs: Antibiotics; Bacteriophage Therapy; Gut Microbiota Modulators; Immunomodulators; Antidiarrheal Agents; Laxatives

4) By Supplements: Synbiotics; Postbiotics; Enzyme Supplements; Vitamin D Supplements; Omega-3 Fatty Acids; Herbal Extracts

5) By Other Products: Functional Foods; Fermented Foods; Beverages; Gut Health Diagnostic Kits; Dietary Fiber Products

Which Market Trends Are Creating New Opportunities In The Gut Microbiota Industry?

Leading companies in the gut microbiota market are concentrating on creating innovative solutions, such as orally delivered fecal microbiota, to tackle various gastrointestinal diseases and disorders. Orally administered fecal microbiota describes a treatment involving the intake of a capsule or pill filled with beneficial bacteria from a healthy donor’s stool to re-establish balance in the gut microbiome. For instance, in April 2023, Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, secured FDA approval for Vowst, which is the first oral fecal microbiota product developed to prevent recurrent Clostridioides difficile (C. difficile) infection (CDI) in individuals aged 18 and older. Vowst is intended for use subsequent to antibacterial treatment for recurrent CDI. This approval signifies a notable advancement in CDI treatment, offering a more accessible and patient-friendly option compared to conventional fecal microbiota transplants, which are typically administered via colonoscopy or enema. Its oral formulation has the potential to enhance treatment adherence and broaden the adoption of microbiome-based therapies in healthcare.

Which Industry Leaders Are Driving Innovation Across The Gut Microbiota Market?

Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

How Is Gut Microbiota Market Demand Varying Across Different Regions?

North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gut Microbiota Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp

Browse Through More Reports Similar to the Global Gut Microbiota Market 2025, By The Business Research Company

Animal Intestinal Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-intestinal-health-global-market-report

Disposable Intestinal Wash Bags Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/disposable-intestinal-wash-bags-global-market-report

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795